imprimis njof, llcdrugHigh PriorityActive

Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.

imprimis njof, llc Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01. recalled by FDA. Presence of particulate matter - Glass like particles.

By RecallRadar Editorial Team

Sourced from FDA. Last reviewed March 4, 2026.

This recall involves safety concerns. Take action promptly.

✨ Plain-English Summary

Is This Recall Still Active?

Status: Yes - Active

This recall is currently active. If your device matches the affected models, follow the official instructions as soon as possible.

Source & Verification

This page summarizes the official notice and keeps key facts easy to verify.

Official source: FDA
Announced by source: December 18, 2025
Last reviewed by RecallRadar: March 4, 2026

What You Should Do

1## Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-
2Agency: FDA | Category: drug Reason: Presence of particulate matter - Glass like particles. What to do:
3Stop using the product if your lot/model matches.
4Check the FDA notice for specifics.

Open Official Recall Notice Get Alerts for imprimis njof, llc Devices

What's Being Recalled

Quoted source excerpt from the official notice.

Presence of particulate matter - Glass like particles.

Who's Affected

Specific models and identifiers listed in the source notice:

Model #1

Lot: 25APR001A, 25APR001B, Expires: 04/03/2026.

#	Model
1	Lot: 25APR001A, 25APR001B, Expires: 04/03/2026.

Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.

Frequently Asked Questions

Is my imprimis njof, llc device affected?

Check the affected models section on this page. The official notice currently lists Lot: 25APR001A, 25APR001B, Expires: 04/03/2026..

What is the remedy for this recall?

## Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01. Agency: FDA | Category: drug Reason: Presence of particulate matter - Glass like particles. What to do: 1. Stop using the product if your lot/model matches. 2. Check the FDA notice for specifics. 3. Follow remedy instructions.

Where can I verify recall details?

Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Keep browsing with these internal hubs: imprimis njof, llc recall hub and Food & Drug recall hub.